Rare Diseases × Endocrine × 1 year × Clear all
NCT02834013 2026-06-03

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting
798 enrolled
NCT06573723 2026-01-14

Institutional Registry of Rare Diseases

Hospital Italiano de Buenos Aires

Recruiting
380 enrolled